U.S. Supreme Court Denies Review of Challenge to Vioxx Settlement Program

On February 22, Skadden successfully represented Merck & Co., Inc. in opposing a petition to the U.S. Supreme Court by plaintiffs challenging the Vioxx resolution program, which settled more than 50,000 personal injury claims.